Cargando…
In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863861/ https://www.ncbi.nlm.nih.gov/pubmed/31745070 http://dx.doi.org/10.1038/s41408-019-0250-4 |
_version_ | 1783471777828044800 |
---|---|
author | Klippel, Zandra Kimball, Amy Tekle, Christina |
author_facet | Klippel, Zandra Kimball, Amy Tekle, Christina |
author_sort | Klippel, Zandra |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6863861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68638612019-11-21 In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 Klippel, Zandra Kimball, Amy Tekle, Christina Blood Cancer J Correspondence Nature Publishing Group UK 2019-11-19 /pmc/articles/PMC6863861/ /pubmed/31745070 http://dx.doi.org/10.1038/s41408-019-0250-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Klippel, Zandra Kimball, Amy Tekle, Christina In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 |
title | In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 |
title_full | In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 |
title_fullStr | In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 |
title_full_unstemmed | In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 |
title_short | In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 |
title_sort | in response to: treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, moreau et al., 2019 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863861/ https://www.ncbi.nlm.nih.gov/pubmed/31745070 http://dx.doi.org/10.1038/s41408-019-0250-4 |
work_keys_str_mv | AT klippelzandra inresponsetotreatmentofpatientswithmultiplemyelomaprogressingonfrontlinetherapywithlenalidomidemoreauetal2019 AT kimballamy inresponsetotreatmentofpatientswithmultiplemyelomaprogressingonfrontlinetherapywithlenalidomidemoreauetal2019 AT teklechristina inresponsetotreatmentofpatientswithmultiplemyelomaprogressingonfrontlinetherapywithlenalidomidemoreauetal2019 |